13 Recruiting Locally Advanced Solid Tumor Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Locally Advanced Solid Tumor
Related Conditions
Top Recruiting Locally Advanced Solid Tumor Studies
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
📍 OHSU — Portland, Oregon
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
📍 University of California San Diego — San Diego, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
📍 University of California Irvine Medical Center — Orange, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
📍 Yale Cancer Center-Yale University — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
📍 City of Hope - Lennar — Irvine, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
📍 UCI Medical Center — Orange, California
View Study & Checklist ➔